Neuroscience • 27 March 2017
London • United Kingdom

Reisa Sperling, MD

  • Director, Center for Alzheimer's Research and Treatment, Brigham and Women's Hospital
  • Professor of Neurology, Harvard Medical School

Dr. Reisa Sperling is a neurologist specializing in the early detection and treatment of Alzheimer’s disease. She is a Professor in Neurology at Harvard Medical School, Director of the Center for Alzheimer Research and Treatment at Brigham and Women’s Hospital, and Director of Neuroimaging for the Massachusetts ADRC at Massachusetts General Hospital. She is the Principal Investigator of the Harvard Aging Brain Study. Dr. Sperling led the NIA-Alzheimer’s Association workgroup to develop guidelines for “Preclinical Alzheimer’s disease,” and currently serves on the Advisory Council of the National Institute on Aging. Dr. Sperling is the Project Leader for the Anti-Amyloid Treatment in Asymptomatic AD (A4) study – a landmark 3 year secondary prevention trial in 1000 clinically normal older individuals with PET amyloid imaging evidence of early Alzheimer’s disease pathology. She is also one of the 2015 awardees of the AAN Potamkin Prize.

This speaker appears at these events: